UniXell Biotechnology Secures FDA IND Clearance for UX-DA003, Achieving China-U.S. Dual Breakthrough in iPSC Parkinson’s Therapy

June 24, 2026
By Ethan Parker

UniXell Biotechnology Secures FDA IND Clearance for UX-DA003, Achieving China-U.S. Dual Breakthrough in iPSC Parkinson’s Therapy

SHANGHAI, June 23, 2026 /PRNewswire/ — UniXell Biotechnology Co., Ltd. ("UniXell") has secured Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) for UX-DA003, its allogeneic induced pluripotent stem cell (iPSC)-derived therapy for Parkinson's…

Read the full release →

News provided by PR Newswire.

Must read

All Posts
Art Community
Art Exhibitions and Features
Art Exhibitions Features
Art History
Art Work
Artistic Journeys
Artwork
Community Well-Being
Design Inspiration
Press Releases
Uncategory

Think Outside the Cup for 7-Eleven, Inc.'s Bring Your Own Cup Day

Think Outside the Cup for 7-Eleven,…

September 10, 2026

The Salvation Army Marks 25 Years Since 9/11 With Stories of Service and a Call to 'Be That Something'

The Salvation Army Marks 25 Years…

September 8, 2026

Lemonade CFO to Participate in Upcoming…

September 8, 2026

Genesis wins AFR Sustainability Leaders 2026…

September 8, 2026

China Merchants Bank Wins CNCF End…

September 8, 2026

Cell Stem Cell: tBE-mediated Base Editing…

September 8, 2026